AGTC Announces Financial Results for the Third Quarter Ended March 31, 2015
May 11, 2015 16:05 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., May 11, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
Novel Gene-Based Therapy for Achromatopsia Demonstrates Functional Rescue of Cone Cells
May 04, 2015 19:15 ET
|
Applied Genetic Technologies Corporation
DENVER, May 4, 2015 (GLOBE NEWSWIRE) -- Researchers from Michigan State University and the University of Pennsylvania presented new preclinical data today, evaluating the efficacy of an...
AGTC Announces Participation in Upcoming Conferences
April 27, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., April 27, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC and 4D Molecular Therapeutics Sign Collaboration Agreement for Gene Therapy Vector Discovery and Product Development
April 20, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and SAN FRANCISCO, April 20, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC) and 4D Molecular Therapeutics (4DMT), leaders in next-generation...
AGTC Appoints Bruce A. Peacock to Its Board of Directors
March 20, 2015 16:05 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., March 20, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Files Investigational New Drug Application for the Treatment of X-Linked Retinoschisis
March 10, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., March 10, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Leadership to Present at Upcoming Scientific and Investor Conferences
February 25, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Announces Financial Results for the Second Quarter Ended December 31, 2014
February 11, 2015 08:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Feb. 11, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Appoints Stephen W. Potter Chief Business Officer
January 29, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC to Present at Phacilitate Cell & Gene Therapy Forum 2015
January 22, 2015 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...